BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34738838)

  • 1. Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving
    Bendig S; Stengel A; Walter W; Meggendorfer M; Baer C; Müller ML; Haferlach T; Kern W; Haferlach C
    Leuk Lymphoma; 2022 Mar; 63(3):747-750. PubMed ID: 34738838
    [No Abstract]   [Full Text] [Related]  

  • 2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T/myeloid.
    Wang W; Beird H; Kroll CJ; Hu S; Bueso-Ramos CE; Fang H; Tang G; Tang Z; Wang F; Takahashi K; You MJ; Khoury JD; Medeiros LJ; Futreal PA
    Leukemia; 2020 Sep; 34(9):2509-2512. PubMed ID: 32099038
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.
    Bezrookove V; van Zelderen-Bhola SL; Brink A; Szuhai K; Raap AK; Barge R; Beverstock GC; Rosenberg C
    Cancer Genet Cytogenet; 2004 Feb; 149(1):72-6. PubMed ID: 15104287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
    Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
    Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
    Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
    Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer Hijacking Drives Oncogenic
    Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
    Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.
    MacLeod RA; Nagel S; Drexler HG
    Cancer Genet Cytogenet; 2004 Aug; 153(1):88-9. PubMed ID: 15325104
    [No Abstract]   [Full Text] [Related]  

  • 11. The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.
    Salaverria I; Akasaka T; Gesk S; Szczepanowski M; Burkhardt B; Harder L; Damm-Welk C; Oschlies I; Klapper W; Dyer MJ; Siebert R
    Genes Chromosomes Cancer; 2012 Apr; 51(4):338-43. PubMed ID: 22420028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Flow Cytometry for Mixed Phenotype and Ambiguous Leukemias.
    Kurzer JH; Weinberg OK
    Clin Lab Med; 2023 Sep; 43(3):399-410. PubMed ID: 37481319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput sequencing identifies an NFIA/CBFA2T3 fusion gene in acute erythroid leukemia with t(1;16)(p31;q24).
    Micci F; Thorsen J; Panagopoulos I; Nyquist KB; Zeller B; Tierens A; Heim S
    Leukemia; 2013 Apr; 27(4):980-2. PubMed ID: 23032695
    [No Abstract]   [Full Text] [Related]  

  • 15. Translocation t(1;16)(p31;q24) rearranging CBFA2T3 is specific for acute erythroid leukemia.
    Micci F; Thorsen J; Haugom L; Zeller B; Tierens A; Heim S
    Leukemia; 2011 Sep; 25(9):1510-2. PubMed ID: 21606959
    [No Abstract]   [Full Text] [Related]  

  • 16. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
    Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
    Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (14;14)(q11;q32) with simultaneous involvement of the IGH and CEBPE genes in B-lineage acute lymphoblastic leukemia.
    Han Y; Xue Y; Zhang J; Wu Y; Pan J; Wang Y; Shen J; Dai H; Bai S
    Cancer Genet Cytogenet; 2008 Dec; 187(2):125-9. PubMed ID: 19027493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
    Montefiori LE; Mullighan CG
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia.
    Chapiro E; Russell LJ; Struski S; Cavé H; Radford-Weiss I; Valle VD; Lachenaud J; Brousset P; Bernard OA; Harrison CJ; Nguyen-Khac F
    Leukemia; 2010 Jul; 24(7):1362-4. PubMed ID: 20485370
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.